CROP/Luc7A, a novel serine/arginine-rich nuclear protein, isolated from cisplatin-resistant cell line

被引:26
作者
Nishii, Y
Morishima, M
Kakehi, Y
Umehara, K
Kioka, N
Terano, Y
Amachi, T
Ueda, K [1 ]
机构
[1] Kyoto Univ, Grad Sch Agr, Div Appl Life Sci, Biochem Lab, Kyoto 6068502, Japan
[2] Kyoto Univ, Grad Sch Med, Dept Urol, Kyoto 6068502, Japan
[3] Osaka City Univ, Sch Med, Osaka 545, Japan
关键词
SR protein; RNA splicing; cisplatin resistance; nuclear protein; differential display;
D O I
10.1016/S0014-5793(99)01744-5
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
A novel putative SR protein, designated cisplatin resistance-associated overexpressed protein (CROP), has been cloned from cisplatin-resistant cell lines by differential display. The N-half of the deduced amino acid sequence of 432 amino acids of CROP contains cysteine/histidine motifs and leucine zipper-like repeats. The C-half consists mostly of charged and polar amino acids: arginine (58 residues or 25%), glutamate (36 residues or 16%), serine (35 residues or 15%), lysine (30 residues, 13%), and aspartate (20 residues or 9%), The C-half is extremely hydrophilic and comprises domains rich in lysine and glutamate residues, rich in alternating arginine and glutamate residues, and rich in arginine and serine residues. The arginine/serine-rich domain is dominated by a series of 8 amino acid imperfect repetitive motif (consensus sequence, Ser-Arg-Ser-Arg-Asp/Glu-Arg-Arg-Arg), which has been found in RNA splicing factors. The RNase protection assay and Western blotting analysis indicate that the expression of CROP is about 2-3-fold higher in mRNA and protein levels in cisplatin-resistant ACHN/CDDP cells than in host ACHN cells. CROP is the human homologue of yeast Luc7p, which is supposed to be involved in 5'-splice site recognition and is essential for vegetative growth. (C) 2000 Federation of European Biochemical Societies.
引用
收藏
页码:153 / 156
页数:4
相关论文
共 28 条
[1]  
Arao S, 1998, MECHANISM OF CISPLATIN RESISTANCE AND ITS CIRCUMVENTION, P215
[2]   RESISTANCE AGAINST CIS-DICHLORODIAMMINEPLATINUM IN CULTURED-CELLS WITH A HIGH CONTENT OF METALLOTHIONEIN [J].
BAKKA, A ;
ENDRESEN, L ;
JOHNSEN, ABS ;
EDMINSON, PD ;
RUGSTAD, HE .
TOXICOLOGY AND APPLIED PHARMACOLOGY, 1981, 61 (02) :215-226
[3]   THE CELL BIOLOGY OF MULTIPLE-DRUG RESISTANCE [J].
BECK, WT .
BIOCHEMICAL PHARMACOLOGY, 1987, 36 (18) :2879-2887
[4]  
BLENCOWE BJ, 1995, RNA, V1, P852
[5]   CISPLATIN RESISTANCE AND MECHANISM IN A VIRAL TEST SYSTEM - SV40 ISOLATES THAT RESIST INHIBITION BY THE ANTITUMOR DRUG HAVE LOST REGULATORY DNA [J].
BUCHANAN, RL ;
GRALLA, JD .
BIOCHEMISTRY, 1990, 29 (14) :3436-3442
[6]   FUNCTIONAL-ANALYSIS OF PREMESSENGER RNA SPLICING FACTOR SF2/ASF STRUCTURAL DOMAINS [J].
CACERES, JF ;
KRAINER, AR .
EMBO JOURNAL, 1993, 12 (12) :4715-4726
[7]   Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity [J].
Caceres, JF ;
Misteli, T ;
Screaton, GR ;
Spector, DL ;
Krainer, AR .
JOURNAL OF CELL BIOLOGY, 1997, 138 (02) :225-238
[8]   RNA-POLYMERASES REACT DIFFERENTLY AT D(APG) AND D(GPG) ADDUCTS IN DNA MODIFIED BY CIS-DIAMMINEDICHLOROPLATINUM(II) [J].
CORDA, Y ;
ANIN, MF ;
LENG, M ;
JOB, D .
BIOCHEMISTRY, 1992, 31 (07) :1904-1908
[9]   INACTIVATION OF TETRAHYMENA RIBOSOMAL-RNA SELF-SPLICING BY CISPLATIN PROCEEDS THROUGH DISSOCIABLE COMPLEXES [J].
DANENBERG, PV ;
SHEA, LCC ;
DANENBERG, KD ;
HORIKOSHI, T .
NUCLEIC ACIDS RESEARCH, 1991, 19 (11) :3123-3128
[10]   ENHANCED DNA-REPAIR AS A MECHANISM OF RESISTANCE TO CIS-DIAMMINEDICHLOROPLATINUM(II) [J].
EASTMAN, A ;
SCHULTE, N .
BIOCHEMISTRY, 1988, 27 (13) :4730-4734